• Home
  • Subscribe
  • Channels
      Acid RefluxAcneAcupunctureAddiction PreventionAesthetic MedicineAgricultureAllergiesAlzheimer’sAnimal HealthAnti-AgingArthritisAsthmaAutistic SyndromeAutoimmunityBeautyBeveragesBlood HealthBrain HealthBreast HealthBreastfeedingBullyingCancer InformationCancer PreventionCannabisCardiologyCaregiversCataract CareCBDCeliacCerebral PalsyCharityChildrens HealthChiropracticChronic IllnessConcierge MedicineCosmetic DentistryCosmetic DermatologyCOVID-19DatingDementiaDental CareDental ImplantsDepressionDermatologyDiabetesDigestiveDisinfectionDivorceDrug & Alcohol RehabilitationEating Disorder ChannelEbolaEducationeHealth Radio AustraliaElectromagnetic Fields (EMFs)Emergency CareEmotional HealthENTEpilepsyErectile DysfunctionEssential TremorEye HealthFamilyFemale HealthFeng ShuiFertilityFibromyalgiaFitnessFoot HealthFunctional MedicineGastrointestinal ChannelGERDGeriatricsGluten-FreeGynecologyHair HealthHair Loss PreventionHealthHealth & Wellness CoachingHealth CareHealth InsuranceHealth MarketingHealth NewsHearing HealthHeart BurnHeart DiseaseHeart HealthHip DysplasiaHormonal TherapyHospiceHygieneHyperbaric Oxygen TherapyHypnosisIn-Home CareIndigestionInfant HealthInfertilityIntegrative MedicineIrritable Bowel Syndrome (IBS)Kidney HealthLegal ChannelLife SupportLyme DiseaseMarriageMassage TherapyMemoryMenopauseMens HealthMental HealthMitochondriaMobile AppsMorgellons DiseaseMosquito RepellentsMoviesMultiple SclerosisNeurology ChannelNeuropathyNon-ProfitNonenalNutritionOnline DatingOpioidsOral HealthOrgan TransplantsOrthopedicOsteoarthritisOsteoporosisPain ManagementPalliative CareParentingPathogenic DiseasePediatricPelvic HealthPersonal DevelopmentPersonality DisordersPharmaceutical ChannelPhysical TherapyPlastic SurgeryPoison ControlPost Traumatic Stress DisorderPostpartum DepressionPostpartum RecoveryPR and MarketingPregnancyProbioticsProstate InformationPsoriasisPsychologyPsychotherapyPulmonaryPulmonary EmbolismRadiologyRare DiseasesRefluxRehabRehabilitationRelationshipsResearchRespiratory ChannelRetirementSafetyScoliosisSenior CareSexual HealthSkin CareSleepSleep ApneaSmartphone AppsSmoking CessationSocial AnxietySpa HealthSpecial NeedsSpinal Health ChannelStem Cell TherapyStress ManagementStroke RecoverySuicide PreventionSupplement ChannelSurgical AccessoriesTechnologyTelemedicineTelemental HealthTelenutritionTherapyTinnitusTraditional Chinese MedicineTravel Health CareTrichotillomaniaDefaultTagUrologyUV DisinfectionVascular BirthmarkVascular DiseaseVideo GamesWeight ManagementWhole-Body DonationWorkplaceWound CareYogaZika Virus
  • Profile
  1. All Episodes

Friday Sep 07, 2012

MediciNova Inc., developing treatments for conditions ranging from asthma to drug addiction

MichaelCoffee2_small.jpg


Michael Coffee is Chief Business Officer at MediciNova Inc., a publicly traded biopharmaceutical company focused on acquiring and developing treatments for conditions with unmet needs, ranging from asthma to drug addiction joins eHealth Radio and the Asthma Information Channel.


Listen to interview [audio player below] with host Eric Michaels & guest Michael Coffee discuss the following:

  • Your company is working on a treatment called MN-221 for severe, or advanced exacerbations of asthma. Why is severe asthma still an unmet need?
  • How much money does an average asthma-related hospital stay cost?
  • When is an advanced ex-acerbation of asthma most likely to occur, and who is most likely to suffer from this?
  • Can MN-221 work in patients with advanced COPD?
  • Meth addiction is a very serious public health problem. Can you explain how the other compound you are working on, ibudilast, might help prevent relapses in meth users?

eHealthLARGE.jpg


Michael Coffee is Chief Business Officer of MediciNova.  He previously was Senior Vice President, Sales and Marketing for Adamas Pharmaceuticals, Inc. from May 2009 to February 2010.  From February 2005 to May 2009, Mr. Coffee was Chief Business Officer of Avigen, Inc., which was acquired by MediciNova in December 2009.


Prior to joining Avigen, Mr. Coffee co-founded the Alekta Group, LLC, a consulting firm, in 2004 to provide a comprehensive range of pharmaceutical development consulting services to emerging pharmaceutical companies.


From 2001 to 2004 Mr. Coffee served as President and Chief Operating Officer of Amarin Pharmaceuticals, Inc., the U.S. drug development and marketing subsidiary of Amarin Corporation PLC. Mr. Coffee also served as President and Chief Operating Officer of Elan Pharmaceuticals, North America from 1998 to 2001 and held marketing and executive management positions, including President and Chief Operating Officer, of Athena Neurosciences, Inc. between 1991 and 1998.


Mr. Coffee received a B.S. in biology from Siena College and an Advanced Management degree from Amos Tuck School of Business.


Medicinova.jpg


Related Web Site: www.medicinova.com


  • Download

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

To leave or reply to comments,
please download free Podbean App.

iOS appAndroid app

Copyright 2010 - 2022 eHealth Radio Network. All rights reserved.

Podcast Powered By Podbean